Balance Labs, Inc.
BLNC
$0.2152
$0.032217.60%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 4.65% | 1.07% | |||
| Gross Profit | -4.65% | -1.07% | |||
| SG&A Expenses | 75.45% | -54.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.13% | -23.54% | |||
| Operating Income | -23.13% | 23.54% | |||
| Income Before Tax | 94.56% | 38.95% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 94.56% | 38.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 94.56% | 38.95% | |||
| EBIT | -23.13% | 23.54% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 94.44% | 39.33% | |||
| Normalized Basic EPS | -11.43% | 16.67% | |||
| EPS Diluted | 94.44% | 39.33% | |||
| Normalized Diluted EPS | -11.43% | 16.67% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||